

ICAgen, a biopharmaceutical company, develops novel orally-administered small molecule drugs that modulate ion channel targets.
| Headquarter | 4222 Emperor Blvd, Suite 350 Durham, NC United States of America |
|---|---|
| Website | www.icagen.com |
| Founding Date | 1992 |
| Tel | (919)941-5206 |
| Company Status | Private |
Icagen competitors include Biogen, MyoKardia, and Reata Pharmaceuticals. See below how Icagen compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.

Richard Cunningham CEO / President
Richard Cunningham serves as the CEO / President of Icagen.

Clive Kabatznik Director
Clive Kabatznik serves as the Director for Icagen. Clive started at Icagen in March of 2013. Clive is based in the West...

Neil Castle VP Research
Neil Castle serves as the VP Research for Icagen. Neil started at Icagen in April of 2016. Neil is based in the...

Paul August Vice President
Paul August serves as the Vice President of Icagen. Paul currently resides in the Tucson, Arizona Area.

Anil Nair Vice President
Anil Nair serves as the Vice President of Icagen. Anil currently resides in the Tucson, Arizona Area.

No Recent Jobs found for Icagen on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Icagen address?
Icagen location is at 4222 Emperor Blvd, Suite 350
Who are Icagen competitors?
Icagen main competitors are Biogen, MyoKardia, Reata Pharmaceuticals
Who is Icagen leadership?
Clive Kabatznik, Neil Castle & Paul August are part of Icagen leadership, Richard Cunningham is the CEO